Following the WSJ's detailed account of the SpaceX-xAI merger, I wanted to share my reading of the deal and its broader implications.
The headline is a $1.25 trillion mega-merger combining Musk's rocket and satellite business with his AI startup. The reality, in my view, is a carefully sequenced liquidity and valuation crystallization event ahead of a summer IPO.
The mechanics are telling:
• SpaceX's board self-valued at $1 trillion — a 25% premium to the $800 billion secondary market price just weeks prior — with no independent fairness opinion.
• xAI was valued at $250 billion despite significant cash burn, recent executive departures, and no proven revenue model at scale.
• Morgan Stanley advised both sides of the transaction (Musk controls both entities), eliminating the adversarial tension that typically protects minority shareholders.
• The deal closed in two days. This was not a negotiation.
• An IPO was announced immediately thereafter for this summer.
The strategic narrative — orbital data centers, AI-space convergence, the "K2" entity references to the Kardashev scale — provides an ambitious wrapper around what is fundamentally a financial engineering exercise. The sequence is clear: merge the capital-intensive AI business into the strongest asset (Starlink/SpaceX), anchor xAI's valuation to a real cash-generating business, and IPO the combined entity into peak AI enthusiasm.
Several structural concerns deserve attention:
• SpaceX legacy investors have been diluted roughly 20% by xAI shareholders at what many consider an inflated valuation.
• xAI faces brutal competition from OpenAI, Anthropic, and Google, with no discernible moat for Grok.
• The orbital data center technology is entirely unproven — the University of Chicago professor quoted in the article draws a direct parallel to AOL-Time Warner, the defining peak-cycle merger of the dot-com era.
• IPO timing (summer 2025) appears optimised for the seller, not the buyer — maximum AI narrative momentum before potential revenue disappointments materialise across the sector.
The Tesla dimension adds another layer of concern. Musk's decision to repurpose Tesla manufacturing capacity towards Optimus humanoid robots raises serious questions about capital allocation discipline. Humanoid robotics remains years — likely a decade or more — from viable commercialisation at scale. The core engineering challenges around dexterity, reliability, battery life, and real-world autonomy are formidable, and no player in the industry is close to solving them. Redirecting production lines away from electric vehicles — a business already under pressure from declining deliveries and fierce Chinese competition — towards a product with no clear path to revenue looks less like strategic vision and more like narrative management. It provides Musk with a new "moonshot" story for Tesla at precisely the moment the EV growth narrative is faltering, while conveniently justifying lower near-term vehicle output.
The broader context reinforces my reading. Tesla faces declining deliveries, intensifying Chinese competition, and growing brand risk from Musk's political exposure. Space launch competition is accelerating (Blue Origin, Rocket Lab, state-backed programmes). Musk's personal liquidity needs are considerable — Tesla compensation litigation, legacy X/Twitter debt, xAI capital expenditure, and political commitments.
The contrarian case: if Starlink's near-monopoly in LEO broadband delivers the economics bulls expect, the core SpaceX business could support the valuation regardless of xAI's trajectory. The AI narrative becomes a free option rather than a liability. At $1.25 trillion, however, much of that is already priced in.
My view: this is peak-narrative monetisation across the Musk empire. Whether it is merging xAI into SpaceX ahead of an IPO, or pivoting Tesla factories towards humanoid robots with no commercial horizon, the pattern is consistent — replace weakening fundamentals with ambitious new storylines to sustain valuations. The "space-AI convergence" story is the packaging. The IPO is the product.
Happy to discuss implications for positioning.
Best regards,
Laurent